REU

(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(2S)-1-(methylamino)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide

Created:	2023-08-22
Last modified:	2023-11-08

Find Related PDB Entry
1 entries where REU is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	2
Bond Count	56
Aromatic Bond Count	17

2D diagram of REU

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(4S)-6-chloro-N-(isoquinolin-4-yl)-2-[(2S)-1-(methylamino)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide
Systematic Name (OpenEye OEToolkits)	(4~{S})-6-chloranyl-~{N}-isoquinolin-4-yl-2-[(2~{S})-1-(methylamino)-1-oxidanylidene-propan-2-yl]-3,4-dihydro-1~{H}-isoquinoline-4-carboxamide
Formula	C₂₃ H₂₃ Cl N₄ O₂
Molecular Weight	422.907
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CNC(=O)C(C)N1Cc2ccc(Cl)cc2C(C1)C(=O)Nc1cncc2ccccc21
SMILES	CACTVS	3.385	CNC(=O)[CH](C)N1C[CH](C(=O)Nc2cncc3ccccc23)c4cc(Cl)ccc4C1
SMILES	OpenEye OEToolkits	2.0.7	CC(C(=O)NC)N1Cc2ccc(cc2C(C1)C(=O)Nc3cncc4c3cccc4)Cl
Canonical SMILES	CACTVS	3.385	CNC(=O)[C@H](C)N1C[C@@H](C(=O)Nc2cncc3ccccc23)c4cc(Cl)ccc4C1
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@@H](C(=O)NC)N1Cc2ccc(cc2[C@@H](C1)C(=O)Nc3cncc4c3cccc4)Cl
InChI	InChI	1.06	InChI=1S/C23H23ClN4O2/c1-14(22(29)25-2)28-12-16-7-8-17(24)9-19(16)20(13-28)23(30)27-21-11-26-10-15-5-3-4-6-18(15)21/h3-11,14,20H,12-13H2,1-2H3,(H,25,29)(H,27,30)/t14-,20+/m0/s1
InChIKey	InChI	1.06	JYNPSSIRIGNSBA-VBKZILBWSA-N

Related Resource References

Resource Name	Reference
PubChem	169408339

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.